Timely article in Popular Science regarding the USPTO and its backlog The passage below is from an article in Popular Science, and is timely given the current workload of the USPTO and statements by Director Dudas that application pendency will continue to increase: The Patent Office Has Become A National Disgrace THE Patent Office, in Washington, D. C, recently sent to a workman in a chemical […] Continue Reading →
Tomorrow at the Supreme Court: Oral argument in Quanta v. LG Tomorrow the Supreme Court will hear oral argument in Quanta Computer, Inc. v. LG Electronics, Inc. (No. 06-937). The case will determine whether patent owners who sell products embodying their patents conditionally are able to recover damages for patent infringement if the products are subsequently sold beyond the scope permitted by the original sale. The […] Continue Reading →
Amici piling up in lawsuit challenging new claim and continuation rules Although the parties' motions for summary judgment have been filed, the amici keep coming forward in the consolidated lawsuits challenging the new claim and continuation rules. This brings the total number of amici in this case over 30, filing 19 20 (as of 1/4) total briefs. While the vast majority of amici filings support the […] Continue Reading →
AUTM releases 2006 annual licensing survey The Association of University Technology Managers (AUTM) has released its summary report for the 2006 AUTM U.S. Licensing Activity Survey. The yearly survey is an ongoing effort of the organization to assist in informing the public about academic technology transfer professionals in order to improve public understanding of their activities. The 2006 Annual Report reflects […] Continue Reading →
Motions for summary judgment filed in lawsuit challenging claim and continuation rules Yesterday the parties filed their motions for summary judgment in the cases brought by GlaxoSmithKline (GSK) and Dr. Tafas challenging the USPTO's new claim and continuation limit rules. Apparently the earlier order setting the deadline for amicus briefs did not apply to the parties' motions, as earlier speculated. The deadline for briefs in opposition is […] Continue Reading →
Summary judgment deadline now December 27 in lawsuit challenging new rules; one more amicus joins in The deadline for summary judgment motions in the lawsuit challenging the new claim and continutation rules has apparenlty been extended from December 20 to December 27. While no modified scheduling order has yet appeared on PACER, in the court's order yesterday granting leave for the various amici who sought to file briefs at the summary […] Continue Reading →
Summary judgment motions due December 20 in lawsuit challenging new claim and continuation rules It's been awhile since our last update on the lawsuit challenging the USPTO's new claim and continuation limit rules. Here's a brief rundown of what's happened since the court granted Glaxo's motion for preliminary injunction, temporarily preventing implementation of the rules: Tafas noticed the depositions of Jon Dudas (USPTO director), John Doll (commissioner for patents), […] Continue Reading →
First wave of amicus briefs filed in Quanta v. LG, argument set for January 16 Earlier this month, amicus briefs either supporting the Petitioner or neither party were filed with the Supreme Court in connection with Quanta Computer, Inc. v. LG Electronics, Inc (No. 06-937). Our previous coverage of the case can be found in these three posts. The Court also set oral argument for January 16, 2008. Some discussion […] Continue Reading →
Analysis of order enjoining claim and continuation limit rules: almost 100% in Glaxo’s favor All in all, the order granting Glaxo's motion for a preliminary injunction barring enforcement of the USPTO's new claim and continuation limit rules is about everything Glaxo (and patent prosecutors) could have hoped for. The court found that each of the four factors considered when deciding whether to grant an injunction favored Glaxo, although the […] Continue Reading →
Claim and continuation limit rules preliminarily enjoined According to reports, enforcement of the USPTO's new claim and continuation limit rules has been enjoined. Judge James C. Cacheris issued the ruling from the bench after the hearing today on GlaxoSmithKline's motion for preliminary injunction. We'll have more as it develops, including any orders or decisions issued by the court. Update: More detail regarding […] Continue Reading →